EFFICACY OF PHENYTOIN IN PREVENTION OF EARLY POST-TRAUMATIC SEIZURES
AbstractBackground: The use of anti-epileptic drugs for prophylaxis of early post-traumatic seizures after traumatic brain injury has been very promising. The objective of this study was to determine the outcome of phenytoin in prevention of early post-traumatic seizures in moderate to severe traumatic brain injuries and to compare the frequency of seizures in moderate to severe traumatic brain injury, with phenytoin started within 12 hours and after 12 hours of injury. Methods: This cross-sectional study was conducted at Department of Neurosurgery, Ayub Medical Institute, Abbottabad from April to October, 2015. All the patients with moderate to severe head injury presenting within 48 hours of injury were included in this study in consecutive manner. Patients were started on phenytoin and observed for early post-traumatic seizures. Results: A total of 163 patients were included in this study with a mean age of 24.69±10.186 years. One hundred and twenty-two (74.8%) were males and rest of 41 (25.2%) were females. A total of 26 (16%) patients had early post-traumatic seizures. 9.89% patients in whom phenytoin was started within 12 hours had seizures, while 23.11% patients in whom phenytoin was started after 12 hours of injury had seizures, the difference being statistically significant (p-value .018). Conclusion: Frequency of early post-traumatic seizures is high in patients with moderate to severe head injured patients. Anti-epileptics like phenytoin should be started within 12 hours for seizure prophylaxis.Keywords: Phenytoin; Seizures; Early post-traumatic seizures; Prophylaxis; Brain injury; Head injury
Shukla D, Devi BI. Mild traumatic brain injuries in adults. J Neurosci Rural Pract 2010;1(2):82–8.
CDC. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation 2014. [Internet]. [cited 2018 May]. Available from: https://www.cdc.gov/traumaticbraininjury/pubs/congress_epi_rehab.html
World Health Organization. Projections of mortality and burden of disease to 2030: deaths by income group. Available at: http://www.who.int/healthinfo/global_burden_disease/en/
Bruns J Jr, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia 2003;44(Suppl 10):2–10.
Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46(4):470–2.
Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003;44(10):11–7.
Khan AA, Banerjee A. The role of prophylactic anticonvulsants in moderate to severe head injury. Int J Emerg Med 2010 22;3(3):187–91.
Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998;338(1):20–4.
Vespa PM, Miller C, McArthur D, Eliseo M, Etchepare M, Hirt D, et al. Nonconvulsive electrographic seizures after traumatic brain injury result in a delayed, prolonged increase in intracranial pressure and metabolic crisis. Crit Care Med. 2007;35(12): 2830–36
Odebode OT, Sanya EO. Outcome of early posttraumatic seizure: an experience in Nigeria. Niger J Clin Pract 2008;11(3):193–8.
Head Trauma. In: Greenberg MS, editor. Handbook of Neurosurgery. 6th ed. New York, 2006; p.632–97.
Liesemer K, Bratton SL, Zebrack CM, Brockmeyer D, Statler KD. Early post-traumatic seizures in moderate to severe pediatric traumatic brain injury: rates, risk factors, and clinical features. J Neurotrauma 2011;28(5):755–62.
Zafar SN, Khan AA, Ghauri AA, Shamim MS. Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis. BMC Neurol 2012;12:30.
Brouwers MC, Chambers A, Perry J. Can surveying practitioners about their practices help identify priority clinical practice guideline topics? BMC Health Serv Res 2003;3(1):23.
Chang BS, Lowenstein DH. Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003;60(1):10–6.
Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001;42(4):515–24.
Chen JW, Ruff RL, Eavey R, Wasterlain CG. Posttraumatic epilepsy and treatment. J Rehabil Res Dev 2009;46(6):685–96.
Sundararajan K, Milne D, Edwards S, Chapman MJ, Shakib S. Anti-seizure prophylaxis in critically ill patients with traumatic brain injury in an intensive care unit. Anaesth Intensive Care 2015;43(5):646–51.
Chan KH, tharakan J, Pal HK, Khan N, Tan YC. Risk Factors and Phenytoin Prophylaxis for Early Post-Traumatic Seizures among Patients with Traumatic Brain Injury. Malays J Med Sci 2010;17(4):36–43.
Debenham S, Sabit B, Saluja RS, Lamoureux J, Bajsarowicz P, Maleki M, et al. A critical look at phenytoin use for early post-traumatic seizure prophylaxis. Can J Neurol Sci 2011;38(6):896–901.
Szaflarski JP, Sangha KS, Lindsell CJ, Shutter LA. Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis. Neurocrit Care 2010;12(2):165–72.